Lipoprotein Apheresis for Lipoprotein(a)-Associated Cardiovascular Disease

2016212 citationsJournal Articlebronze Open Access

Authors

E. Roeseler

Ulrich Julius

Børge G. Nordestgaard

Winfried Maerz

Asma Noureen

Konrad Schmidt

Abstract

Results of 5 years of prospective follow-up confirm that LA has a lasting effect on prevention of cardiovascular events in patients with Lp(a)-HLP. Patients clinically selected by progressive cardiovascular disease were characterized by a highly frequent expression of small apo(a) isoforms. Only Lp(a) concentration seemed to comprehensively reflect Lp(a)-associated cardiovascular risk, however.

Topics & Keywords

Lipoproteins and Cardiovascular Health Diabetes, Cardiovascular Risks, and Lipoproteins Antiplatelet Therapy and Cardiovascular Diseases

UN Sustainable Development Goals

Good health and well-being

Publication Details

Published in: Arteriosclerosis Thrombosis and Vascular Biology

Volume 36, Issue 9, pp. 2019-2027

DOI: 10.1161/atvbaha.116.307983

Field-Weighted Citation Impact: 25.54